The production of cytokines by the immune system in response to cytosolic DNA plays an important role in host defense, autoimmune disease, and cancer immunogenicity. Recently a cytosolic DNA signaling pathway that is dependent on the endoplasmic reticulum adaptor and cyclic dinucleotide sensor protein STING has been identified. Association of cytosolic DNA with cyclic-GMP-AMP synthase (cGAS) activates its enzymatic activity to synthesize the cyclic dinucleotide second messenger cGAMP from GTP and ATP. Direct detection of cGAMP by STING triggers the activation of IRF3 and NF-kB, and the production of type I interferons and proinflammatory cytokines. The mechanism of how STING is able to mediate downstream signaling remains incompletely understood although it has been shown that dimerization is a prerequisite. Here, we identify a single amino acid change in STING that confers constitutive active signaling. This mutation appears to both enhance ability of STING to both dimerize and associate with its downstream target TBK1.
Introduction
Despite the fact that DNA has long been known to trigger immune responses, only within the past few years have the underlying molecular mechanisms been significantly uncovered. Recently, important progress has been made in the elucidation of a cytosolic DNA signaling pathway involving the stimulator of IFN genes (STING), an endoplasmic reticulum membrane adaptor protein which functions as a sensor for cyclic dinucleotides (CDNs) [1] [2] [3] [4] [5] [6] . In this pathway, cytosolic DNA induces the production of type I interferons (IFNs) and other cytokines in a STING-dependent manner [7] . Several DNA sensors have been proposed to function in this signaling pathway, but only one, cyclic-GMP-AMP (cGAMP) synthase (cGAS), appears to be required for DNA-mediated immune responses regardless of cell type [8] . Binding of DNA to cGAS induces its dimerization and a conformational change that opens up its catalytic pocket, thereby activating the synthesis of the CDN 2'3'-cGAMP from ATP and GTP [9] [10] [11] [12] [13] . cGAMP serves as a secondary messenger to activate STING-dependent signaling by binding to STING and inducing a conformational change, which allows for the activation of the transcription factors IRF3 and NF-kB through the kinases TBK1 and IKK, respectively [2, 5, 6] . It has been demonstrated that dimerization of STING is induced in response to cytosolic DNA and is important for STING activation [5, 14] . Crystal structures of CDNs complexed with the STING dimer interface suggest that binding of CDNs to STING may stabilize its dimeric active configuration [15] .
The cGAS-STING cytosolic DNA signaling pathway is likely to be tightly regulated, as conditions that promote excess cytosolic DNA in mice can lead to autoimmune disease that is dependent on STING [16, 17] . Also, gain-of-function point mutations in human STING have been recently found to be associated with autoinflammatory disease [18] . Thus, overactivation of STING-dependent signaling can lead to dysregulation of the production of cytokines, which may in turn contribute to autoimmune and autoinflammatory disease. On the other end of the spectrum, loss of STING function in mice leads to an increased susceptibility to infection by DNA viruses such as herpes simplex virus 1 (HSV1), vaccinia virus (VACV), and murine gammaherpesvirus 68 (MHV68) [19, 20] . Retroviruses such as HIV, which use reverse-transcribed DNA to propagate, also appear to use the cGAS-STING pathway to induce innate immune system activation [21] . Thus, proper regulation of STING-mediated signaling appears to be critical for the prevention of infectious disease and immune dysregulation in mice and humans. Recently, STING has also been implicated in tumor immunogenicity by mediating the induction of type I IFNs in dendritic cells in response to tumor DNA. The identification and characterization of gain-of-function STING mutants will be useful in understanding the regulatory mechanisms of STING-dependent signaling. In this report, we reveal a single amino acid change in STING that leads to its constitutive activation of downstream signaling, by apparently increasing its propensity to dimerize and associate with TBK1.
Materials and Methods

Cell culture and transfections
HEK293 and HEK293T cells were from ATCC and were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 50 units penicillin/ml, and 50 mg streptomycin/ml (Life Technologies). Transient transfections were using Lipofectamine 2000 (Life Technologies) and luciferase assays were performed as previously described using Renilla as an internal control [22] . For cGAMP treatments, 1ug of cGAMP was complexed with 1ul of Lipofectamine 2000 (Life Technologies) in 100ul total Opti-MEM (Life Technologies) and added to HEK293T cells seeded in 500ul of growth media in 24 well tissue culture plates (Falcon). Samples for all luciferase assays were performed in duplicate and results shown are representative of three independent experiments.
Reagents and plasmids
STING and TBK1 rabbit polyclonal antibodies were from Cell Signaling Technology. FLAG M2 and α-tubulin monoclonal mouse antibodies were from Sigma. Expression constructs for STING were constructed by PCR amplification of the STING cDNA from a full-length cDNA purchased from Open Biosystems (RefSeq: NM_198282) and cloning into the BamHI and EcoRI sites in pcDNA3. The 5' end primer included a BamHI recognition and Kozak consensus sequence prior to the initiation methionine (5'-CGGGATCCGCCACCATGCCCCACTC-CAGCCT-3'). The 3' end primer included an EcoRI recognition sequence and was designed to introduce an AU1 epitope tag to the C-terminus of STING (5'-GGAATTCAGATGTAGCGG-TATGTGTCAGAGAAATCCGTGCGGAG-3'). Codon 132 was mutated to encode arginine instead of histidine as Arg 132 represents the most prevalent haplotype [23] . Missense mutations in the TMEM173 gene found in cancer tissues and cell lines were identified by searching the Catalogue of Somatic Mutations in Cancer (COSMIC) database (cancer.sanger.ac.uk). All mutations in STING were introduced by using the Quikchange Site-Directed PCR Mutagenesis Kit (Agilent Technologies). Lentiviral STING expression constructs were constructed by PCR amplification of wild-type and mutant STING cDNAs and replacement of the LAMP1-mRFP-FLAG insert in pLJM1 (Addgene #34611) between NheI and EcoRI recognition sites. An empty control lentiviral construct was created by cleavage of pLKO-puro FLAG SREBP1 (Addgene #32017) with EcoRI and self-ligation. The IFNβ promoter luciferase constructs pLU-C-IFNβ, pLUC-PRD(III-I) 3 , and pLUC-PRD(II) 2 have been described previously [24] . The mammalian expression plasmid for full-length cGAS, pCMV-SPORT6-cGAS, was purchased from Open Biosystems (Clone ID# 6015929). The form of cGAMP with a 2'-5' phosphodiester linkage between the guanosine and the adenosine (2'3'-cGAMP, InvivoGen) that has been shown to be produced by cGAS was used in stimulation experiments.
Immunoblotting and coimmunoprecipitations
For preparation of whole cell lysates, cells were lysed in Triton X-100 lysis buffer (20 mM TrisHCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 30 mM NaF, 2 mM sodium pyrophosphate, 0.1 mM Na 3 VO 4 , 10mM β-glycerophosphate. 1 mM dithiothreitol) supplemented with complete EDTA-free protease inhibitor cocktail (Agilent Technologies). For coimmunoprecipitation experiments, cells were lysed in CHAPS lysis buffer (40mM Hepes pH 7.4, 2mM EDTA, 10mM sodium pyrophosphate, 0.3% CHAPS, 50mM NaF, 10mM β-glycerophosphate. 1 mM dithiothreitol) supplemented with complete EDTA-free protease inhibitor cocktail (Agilent Technologies). Lysates were incubated with FLAG M2 at 4°C for 1hr. 7ul of 1:1 protein G sepharose slurry (Agilent Technologies) was added and lysates were incubated at 4°C for an additional hr. All proteins were separated by SDS-PAGE and probed using ECL western blotting.
IFNβ measurements and flow cytometry
Human IFNβ enzyme-linked immunosorbent assays were performed according to the manufacturer's instructions (PBL). Briefly, 36 h following plasmid transfection of HEK293 cells with pcDNA3 or STING expression plasmid, supernatants were collected and analyzed. Vesicular stomatitis virus-green fluorescent protein (VSV-GFP) infection measurements were performed as described previously [22] . Cells were analyzed for GFP fluorescence by flow cytometry 12 h following infection (UCLA Flow Cytometry Core).
Results and Discussion
HEK293T cells do not express detectable endogenous STING or cGAS protein, but ectopic STING expression can enhance IFNβ promoter activation and render cells responsive to CDN treatment [2, 8, 25] . We used an IFNβ promoter luciferase assay to assess the effect of various STING missense mutations found in human cancer tissues and cell lines, as identified from searching the COSMIC database (see Materials and Methods). We created expression plasmids for wild-type human STING cDNA and various missense mutants. Each inserted cDNA was designed to contain a codon for arginine at position 232. The Arg 232 allele was previously found to be prevalent upon extensive analysis of DNA sequences from human populations, and thus should be considered wild-type STING [23] . Upon transfection of expression plasmids for wild-type and various mutant STING proteins, we found that several mutant STING proteins were impaired when compared to wild-type in inducing IFNβ promoter activation. However one of the mutants, containing a substitution of arginine 284 to methionine (R284M), was able to induce luciferase reporter activation to a significantly higher extent than wild-type STING (Fig. 1A) . This R284M mutant displayed an enhanced ability to activate luciferase reporter constructs with isolated binding sites for IRF3 or NF-kB, demonstrating that both transcription factors were activated (Fig. 1B) . Alternative substitution of arginine 284 with lysine or threonine (R284K and R284T) also resulted in hyperactive mutants, suggesting that multiple types of amino acids placed at position 284 can confer hyperactivity (Fig. 1A) . Thus, the R284M mutant possesses a significantly enhanced ability to activate IRF3 and NFkB, and the IFNβ promoter. To determine whether the R284M mutant could also induce IFNβ protein production, we transfected wild-type STING or the R284M mutant into HEK293 cells and measured IFNβ levels in tissue culture supernatants. In accordance with our luciferase reporter assay results, we found that the R284M mutant was significantly more potent than wildtype STING in the production of IFNβ protein as well (Fig. 2) .
Type I interferons such as IFNβ can potently inhibit viral replication. Given that the R284M mutant could induce IFNβ production, we tested this STING mutant for antiviral activity as well. We transfected HEK293 cells with wild-type STING or the R284M mutant and subsequently infected cells with recombinant VSV harboring a green fluorescent protein transgene (VSV-GFP). Following infection, we determined the percentage of infected cells by flow cytometry. We found that the percentage of infected cells was significantly diminished in cells transfected with the R284M mutant while wild-type STING had a much lesser effect (Fig. 3) . These results suggest that the R284M mutant can function as a potent inducer of type I interferon and an inhibitor of viral replication.
To examine whether the R284M mutant conferred on STING constitutive active signaling, we created pools of 293T cells stably expressing wild-type STING or the R284M mutant. These cells were compared in IFNβ promoter luciferase assays in the presence or absence of cGAMP or cGAS cotransfection. We found that vector control cells were not sensitive to treatment with cGAMP or expression of cGAS, as expected, due to the absence of STING (Fig. 4) . However, wild-type STING stable expression was able to confer on 293T cells IFNβ promoter activation only in the presence of cGAMP or cGAS transfection, consistent with previous findings [25, 26] . In contrast, cells with stable expression of the R284M mutant displayed robust IFNβ promoter activation in the presence or absence of cGAMP or cGAS (Fig. 4) . These results indicate that the R284M mutation renders STING-dependent signaling constitutively active.
Dimerization of STING has been previously shown to occur following the introduction of cytosolic DNA and to be critical for STING-dependent signal transduction [5, 14] . Upon analysis of cell lysates from cells expressing wild-type STING and the R284M mutant by SDS-PAGE and immunoblotting, we found that the R284M mutant displayed a band of predicted molecular weight 35kD along with a slower mobility band corresponding with a molecular weight of 70kD, consistent with a dimeric species of STING (Fig. 5 ). This dimeric species was not prominent with wild-type STING and was disrupted by heating samples at 95°C. This result suggests that the R284M mutant has an enhanced ability to form SDS-resistant dimers, which may be related to its elevated IFNβ inducing activity.
One possible mechanism whereby the R284M mutant may be constitutively active may be through altered binding to downstream target proteins. Previously, STING was been shown to associate its downstream target kinase, TBK1, and this association was found to be enhanced upon CDN binding [5, 14] . In order to examine the ability of the R284M mutant to bind TBK1, we performed coimmunoprecipitation experiments in HEK293T cells transfected with wildtype STING or the R284M mutant. We found that wild-type STING was able to weakly pull down endogenous TBK1 (Fig. 6) . In contrast, the R284M mutant was able to coimmunoprecipitate significantly more TBK1. We also tested a previously characterized inactive mutant of STING, L374A, which is completely inactive in inducing IRF3 activation and IFNβ production [27] . This mutant displayed no detectable binding to TBK1. Thus, the R284M mutant has an enhanced ability to bind to TBK1, and this difference provides a possible explanation for its constitutive active state.
Dimerization of STING has been previously shown to be essential for IFNβ induction in response to cytosolic DNA sensing. Our results suggest that the R284M mutation may trigger constitutive active STING-dependent signaling by facilitating STING dimerization and/or TBK1 binding and activation. Although dimerization and TBK1 binding both are correlated with activation of STING-dependent signaling, it remains to be seen whether TBK1 association is dependent on STING dimerization as a previous report found no defect in binding of two dimerization impaired STING mutants to TBK1. Interestingly, Arg 284 is located in the STING C-terminal tail, which is predicted to lie in the lumen of the endoplasmic reticulum, separate from the aa 153-177 region that has previously been shown to participate in dimerization [5, 14] . Given that consititutive active STING-dependent signaling can be triggered by multiple types of residues substituted at Arg 284, this residue appears unlikely to be involved directly in dimerization interactions. Instead, we propose that mutation of Arg 284 may promote or inhibit binding of a cellular factor that stabilizes or impairs STING dimerization, respectively. For instance, it is possible that the R284M mutation interferes with binding of a negative regulatory protein that interferes with dimerization. The recently discovered STING binding partner and negative regulator, NLRC3, is a possible such candidate protein [28] . Identification of the molecular mechanism of how the R284M mutant renders STING constitutively active is likely to reveal insights into how STING-dependent signaling is regulated. Also, these studies may be helpful in guiding the construction of biological agents that can enhance the immune response to vaccines or to promote host defense.
